Q3 revenue 9% below ARCe, adj. EBITDA 20% belowNIBD at 99.6m vs ARCe 95.7m, NIBD adj. EBITDA 2.7x vs. ARCe at 2.5x and 2.7x last quarterAnother negative revision to guidance, now see EBITDA ~37.0m (37.5m), with activity uptick in Q4Market perform reiterated
